超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

美國Covidien
Covidien(柯惠)的前身是泰科醫療(Tyco Healthcare)。
Covidien Ltd（紐約證券交易所：COV、百慕大證券交易所：COV）是全球領先的衛生保健產品公司，其創建革新的醫療解決方案，通過臨床領導能力及卓越的表現來使病人實現更好的結果，并實現價值。Covidien制造、分銷多種業界領先的產品線，并為這些產品線提供服務，包括外科設備、基于能量的設備、呼吸和監控解決方案、病人護理與安全產品、影像解決方案、醫藥產品、醫療用品。2006年，Covidien的收入達到近100億美元，在世界上的57個國家中雇有43,000名員工，其產品銷往130多個國家。2007年7月2號開始在紐約證券交易所和百慕大證券交易所進行交易，這意味著公司首次成為獨立的多元化醫療保健產品公司。這也表示眾所周知的Tyco Healthcare業務最近從Tyco International中正獨立。

　　憑借業界領先的品牌名稱（包括：Autosuture、Kendall、Mallinckrodt、Nellcor、Puritan Bennett、Syneture、U.S.Surgical和Valleylab），Covidien在醫療設備、影像解決方案、醫藥產品、醫療用品以及零售產品產品等五大業務部門在市場上競爭。2006年，Covidien收益達到96億美元，其中三分之一以上的銷售額是在美國以外實現的。 Covidien在57個國家雇有43,000名員工，其產品銷往130多個國家。

Covidien五大業務部門的特色
　　醫療設備部（占銷售的59％）

醫療設備部是最大的業務部門，在2006年其凈銷售額達到了57億美元。
這一多樣化產品部門在多種醫療設備市場是全球領先者，其單一產品的銷售額不超過總銷售額的1％。
體現了Covidien在全球廣泛的足跡，醫療設備銷售中有54％是在美國以外實現的。
對于外科設備、能量設備、呼吸和監控解決方案、病人護理和安全產品以及眾多革新產品來說，醫療設備部是最重要的部門。
　　影像解決方案部（占銷售的9％）　　

在2006年，影像解決方案產品的凈銷售額達90億美元。
Covidien影像解決方案部以最精確的早期疾病診斷為終極目標，在生產多種形態的放射性藥劑（X-ray、MRI和核醫療）、造影劑和造影交付系統方面是全球領先者。
遵循全企業創新哲學，影像解決方案部將醫療影像技術從注重‘解剖和功能影像技術轉移到‘分子級影像技術’上。這種轉變可幫助臨床醫生在更早的階段進行疾病診斷、治療和監控。
　　醫藥產品部（占銷售額的13％）

2006年實現的凈銷售額達到12億美元，擁有多個產品線，從配藥醫藥品到藥物活性成分以及特制化學產品。
Covidien是美國第九大醫藥公司（擁有眾多配藥處方）
作為世界上控制中樞神經類物質的最大制造商，Covidien是病人安全與及控制中樞神經類物質調節方面的先驅。
Covidien也是醋氨酚以及其它多種止痛藥品的全球領先者
　　醫療用品部（占銷售額的10％）

在2006年凈銷售額達近10億美元，醫療用品部是病人護理材料領域的領先者。
Covidien的各種產品讓手術室、護理站和醫師的辦公室中擁有最高質量的臨床材料。
產品線包括：傷口護理材料、醫療外科產品、原始設備制造商產品、失禁用品（歐洲）以及其它產品。
在核心醫療用品類中，Covidien的市場份額位居第一或第二。
　　零售產品部（占銷售額的9％）

在零售產品部門，Covidien是北美地區自有品牌成人失禁產品、嬰兒護理產品以及女性衛生產品領域的領先制造商，在2006年的凈銷售額達到8億美元。
在美國20家頂級零售商中，Covidien是為17家提供自有品牌成人失禁產品、嬰兒護理產品以及女性衛生產品的獨家或者多家授權供貨商。

At Covidien, we're passionate about making doctors, nurses, pharmacists and other medical professionals as effective as they can be. From Autosuture to Valleylab, from Kendall to Mallinckrodt, our industry-leading brands are known worldwide for uncompromising quality.

Through ongoing collaboration with medical professionals and organizations, we identify clinical needs and translate them into proven products and procedures. Over the years, we've pioneered a number of medical advances including contrast media, pulse oximetry, electrosurgery, surgical stapling and laparoscopic instrumentation.

Offering an extensive product line that spans medical devices, imaging solutions, pharmaceuticals and medical supplies, we serve healthcare needs in hospitals, long-term care and alternate care facilities, doctors’ offices and in the home.

International in every respect Covidien is part of the local fabric of the communities where we operate. Deriving 45% of our sales from outside the United States, Covidien's success wouldn’t be possible without the dedication of our 41,000 employees, who live in 59 countries. More than two-thirds of our colleagues work in 60 manufacturing facilities, located in 16 countries. In addition, more than 4,800 sales representatives in more than 50 countries meet our customers’ needs every day.

Strategic Initiatives, Core strengths At Covidien, we believe that supporting the lifesaving work of medical professionals and emphasizing growth are not mutually exclusive. In fact, our financial stability enables us to hold to our vision of being an essential resource to the healthcare profession and therefore to doing our part to improve patient outcomes.

With that in mind, we have outlined the following strategic initiatives:

Focus on Growth
Commitment to Innovation
Leveraging Our Global Structure
Driving Operational Excellence
Increased Portfolio Management
We're confident that we will succeed in these areas because of our core strengths:

Scale, product diversity and reach. As one of the largest global manufacturers and marketers in the healthcare industry, our scale and diversity allow us to invest wisely in infrastructure and technology and to develop lower cost sources of supply and global distribution. We offer products in a number of high growth healthcare areas, including laparoscopic surgery, electrosurgery, biosurgery, sleep therapy and pain management.
A portfolio of leading brands. Our brands are among the most well-known and respected in the healthcare field. Quality and reliability are their hallmarks.
Strong customer relationships. Our sales force develops and maintains strong relationships with clinician decision makers. We foster these relationships by providing extensive clinical education through dedicated training centers, by sponsoring fellowships and offering other continuing education programs.
Operational excellence. We have a history of developing and manufacturing high-quality products in a cost-effective manner. Throughout our organization, we are committed to Six Sigma, Design for Six Sigma, Lean Manufacturing and strategic sourcing initiatives to ensure product availability. We employ strict safety and quality controls to reduce disruption throughout the supply chain.
Our aim is to enhance growth by increasing research and development initiatives, pursuing targeted acquisition opportunities and enhancing our global infrastructure, including sales, marketing and distribution.